Literature DB >> 8863285

Rectal absorption of omeprazole from suppository in humans.

M S Choi1, S J Chung, C K Shim.   

Abstract

The oral absorption of omeprazole is incomplete, in part due to first-pass metabolism. We investigated the feasibility of rectal administration of omeprazole by comparing its absorption from a Witepsol H15-based rectal suppository and an orally administered commercial gelatin capsule in 10 male volunteers. Profiles of plasma concentration between two preparations (20 mg) were not statistically different, indicating that the rate and the extent of absorption were similar. Paired t-test revealed no significant differences in area under the curve, mean residence time, and time to peak concentration between two preparations. On the other hand, lag time of absorption and peak concentration were statistically different (p < 0.05) between these preparations. Under these experimental conditions, the rectal route did not produce an improvement in the extent of absorption over an oral capsule.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8863285     DOI: 10.1021/js950375w

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  4 in total

1.  Possible interethnic differences in omeprazole pharmacokinetics : comparison of Jordanian Arabs with other populations.

Authors:  Sireen Shilbayeh; Maha F Tutunji
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

2.  Formulation and evaluation of omeprazole tablets for duodenal ulcer.

Authors:  A Choudhury; S Das; S Bahadur; S Saha; A Roy
Journal:  Indian J Pharm Sci       Date:  2010-07       Impact factor: 0.975

3.  Rectal Omeprazole in Infants With Gastroesophageal Reflux Disease: A Randomized Pilot Trial.

Authors:  Petra Bestebreurtje; Barbara A E de Koning; Nel Roeleveld; Catherijne A J Knibbe; Dick Tibboel; Bianca van Groen; Cees P van de Ven; Frans B Plötz; Saskia N de Wildt
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2020-10       Impact factor: 2.441

4.  Development and Stability Study of an Omeprazole Suppository for Infants.

Authors:  Petra Bestebreurtje; Nel Roeleveld; Catherijne A J Knibbe; Adriaan A van Sorge; Frans B Plötz; Saskia N de Wildt
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2020-10       Impact factor: 2.441

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.